Showing 4031-4040 of 10627 results for "".
TYK2 Inhibition with Zasocitinib Delivers Early Benefit Across PsA Domains
https://reachmd.com/programs/dermconsult/tyk2-inhibition-with-zasocitinib-delivers-early-benefit-across-psa-domains/32812/Burden and pathophysiology of APOL1 kidney disease
https://reachmd.com/programs/kdigo-conversations-nephrology/burden-and-pathophysiology-of-apol1-kidney-disease/35711/Burden and pathophysiology of APOL1 kidney diseaseGlacial Rx, R2 Technologies
https://reachmd.com/topics/energy-based-devices/glacial-rx-r2-technologies/35143/Success of Adalimumab Dose Escalation & De-Escalation in Ulcerative Colitis
https://reachmd.com/programs/Audioabstracts/success-of-adalimumab-dose-escalation-and-de-escalation-in-ulcerative-colitis/10611/How effective is escalating and de-escalating the dose of adalimumab in your patients with ulcerative colitis?IQ vs. EQ: Is Emotional Intelligence Just as Important?
https://reachmd.com/programs/primary-care-today/iq-vs-eq-is-emotional-intelligence-just-as-important/10624/Most of the work we do in school looks to our IQ for our understanding, but should we be recognizing emotional intelligence in everyday life?Dual Impact of 4CMenB: Strong Meningococcal B Protection and Waning Gonorrhea Immunity After Five Years
https://reachmd.com/programs/clinicians-roundtable/dual-impact-of-4cmenb-strong-meningococcal-b-protection-and-waning-gonorrhea-immunity-after-five-years/37105/MS Relapse vs Pseudo-Relapse After Infection: COVID-19 Shows Divergent Risk Pattern
https://reachmd.com/programs/neurofrontiers/program-name/36357/Timing of benefits of intentional weight loss in cardiometabolic disease
https://reachmd.com/cme/obesity/timing-of-benefits-of-intentional-weight-loss-in-cardiometabolic-disease/17669/5' education - Mar. 20, 2023 - Naveed Sattar, MD, PhDObagi’s Skintrinsiq System
https://reachmd.com/topics/skincare/obagis-skintrinsiq-system/35124/Iron Sequestration in Microbiota Biofilms in Treatment for IBD
https://reachmd.com/programs/Audioabstracts/iron-sequestration-in-microbiota-biofilms-in-treatment-for-ibd/10712/This integrative study provides deeper understanding of the interactivity between microbiota and anti-inflammatory drugs currently used to treat IBD.